Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and Lactulose

Clinical trial NCT04073290 · RECRUITING

Trial details

NCT number: NCT04073290
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Hepatic Encephalopathy Cirrhosis, Liver Portal Hypertension Liver Diseases Pathological Processes

Start date: 2020-01-21
Primary completion: 2026-09-30
Enrollment: 238

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.